查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1574260

囊肿纤维化设备市场：按产品、最终用户、年龄层、治疗方法- 全球预测 2025-2030

Cystic Fibrosis Devices Market by Product (Accessories, Devices), End User (Ambulatory Surgical Centers, Clinics, Homecare Settings), Age Group, Therapy - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 190 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

囊肿纤维化设备市场2023年估值为29.3亿美元，预计到2024年将达到32亿美元，复合年增长率为10.87%，到2030年将达到60.4亿美元。

囊肿纤维化(CF) 设备涵盖一系列旨在协助管理和治疗囊肿纤维化是一种影响呼吸、消化器官系统和生殖系统的遗传性疾病。这些设备包括雾化器、气道系统、氧气浓缩机等，对于透过缓解呼吸道症状和增强肺功能来改善患者的生活品质至关重要。 CF 的慢性性质和终身护理的需要强调了对这些设备的需求，这需要促进药物输送、帮助清除粘液并确保充足的氧气供应。应用程式涵盖医院、诊所和居家照护，最终用户包括患者、医疗保健提供者和看护者。市场成长受到生物技术进步、对囊肿纤维化认识的提高以及政府加强医疗基础设施的努力的强烈影响。个人化医疗和远端医疗服务的兴起带来了潜在的商机，因为它们为囊性纤维化患者带来了更量身定制和易于使用的治疗选择。公司应该透过对远端医疗设备和个人化护理服务系统的研发投资来利用这些趋势。然而，该市场也存在局限性，包括设备成本高、低收入地区的可及性有限以及创新的监管途径复杂。患者数量少也是一个重大挑战，这可能会限制大规模研究和开发的奖励。完美的创新领域包括开发便携式和更高效的气道设备，整合数位健康解决方案以更好地病患监测，以及探索基因疗法的进步以提供更全面的治疗选择。市场竞争激烈，对研发的大量投资以及科技公司和医疗保健提供者之间的合作伙伴关係是永续成长的关键。成功创新并驾驭监管环境的公司将能够更好地占领这个不断成长的市场。

主要市场统计
基准年[2023] 29.3亿美元
预测年份 [2024] 32亿美元
预测年份 [2030] 60.4亿美元
复合年增长率（%） 10.87%

市场动态：快速发展的囊肿纤维化设备市场的关键市场洞察

供需的动态交互作用正在改变囊肿纤维化设备市场。透过了解这些不断变化的市场动态，公司可以准备好做出明智的投资决策、完善策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，并了解消费行为及其对製造成本的影响，并更清楚地了解对采购趋势的影响。

  • 市场驱动因素
    • 扩大囊肿纤维化早期诊断的宣传活动和政府倡议
    • 新型囊肿纤维化治疗装置的临床试验扩展和核准
    • 与医疗机构和医疗设备製造商合作开发囊肿纤维化解决方案
    • 越来越多地采用个人化医疗方法来治疗囊肿纤维化
  • 市场限制因素
    • 严格的监管要求和漫长的核准流程阻碍了新设备的推出。
    • 研究和开发的资金和资源有限，减缓了囊肿纤维化治疗的创新。
  • 市场机会
    • 开发数位平台和行动应用程式以加强对囊肿纤维化患者的护理和支持
    • 将人工智慧整合到囊肿纤维化设备诊断和监测中
    • 采用多学科护理方法建立囊肿纤维化诊所
  • 市场挑战
    • 特定行业的挑战：满足有限的患者数量并确保囊肿纤维化治疗设备製造商的市场盈利
    • 行业特定的挑战：将先进技术整合到囊肿纤维化设备中，同时保持经济性和易用性

波特的五力战略工具驾驭囊肿纤维化设备市场

波特的五力架构是了解囊肿纤维化设备市场竞争格局的关键工具。波特的五力框架为评估公司的竞争地位和探索策略机会提供了清晰的方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势，解决弱点并避免潜在的挑战，从而确保更强大的市场地位。

PESTLE分析：了解囊肿纤维化设备市场的外部影响

外部宏观环境因素在塑造囊肿纤维化设备市场的绩效动态方面发挥着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并为他们做出积极主动的决策做好准备。

市场占有率分析 了解囊肿纤维化设备市场的竞争格局

对囊肿纤维化设备市场的详细市场占有率分析可以对供应商的绩效进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、分散和整合的趋势，为供应商提供了製定策略决策所需的洞察力，使他们能够在日益激烈的竞争中占有一席之地。

FPNV 定位矩阵囊肿纤维化设备市场供应商的绩效评估

FPNV 定位矩阵是评估囊肿纤维化设备市场供应商的重要工具。此矩阵允许业务组织根据供应商的商务策略和产品满意度评估供应商，从而做出符合其目标的明智决策。这四个象限使您能够清晰、准确地划分供应商，并确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析和建议描绘了囊肿纤维化设备市场的成功之路

对于旨在加强其在全球市场的影响力的公司来说，对囊肿纤维化设备市场的策略分析至关重要。透过审查关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战，利用新的商机，并取得长期成功。

本报告对市场进行了全面分析，涵盖关键重点领域：

1. 市场渗透率：对当前市场环境的详细审查、主要企业的广泛资料、对其在市场中的影响力和整体影响力的评估。

2. 市场开拓：辨识新兴市场的成长机会，评估现有领域的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监理核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新：重点在于有望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，以帮助相关人员做出明智的决策：

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品、区隔市场和地区提供最佳投资机会？

3.塑造市场的主要技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 扩大囊肿纤维化早期诊断的宣传活动和政府工作
      • 扩大新型囊肿纤维化治疗装置的临床试验与核准
      • 医疗机构与医疗设备製造商合作开发囊肿纤维化解决方案
      • 在囊肿纤维化治疗中越来越多地采用个人化医疗方法
    • 抑制因素
      • 严格的监管要求和漫长的核准流程阻碍了新设备的推出
      • 用于研发的资金和资源有限，导致囊肿纤维化治疗的创新缓慢
    • 机会
      • 创建数位平台和行动应用程式以加强对囊肿纤维化患者的护理和支持
      • 将人工智慧融入囊肿纤维化诊断和监测
      • 建立囊肿纤维化诊所，采用多学科护理方法
    • 任务
      • 特定产业的挑战：为有限的患者群体提供服务并确保囊肿纤维化治疗设备製造商的市场盈利
      • 特定产业的挑战：整合先进技术，同时保持囊肿纤维化设备的经济性和易用性
  • 市场区隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社群
    • 技术的
    • 合法地
    • 环境

第六章囊肿纤维化设备市场：副产品

  • 配件
    • 面具
    • 感应器
    • 管子
  • 装置
    • 气道清理装置
    • 高频胸壁振动装置
    • 吸入器
    • 喷雾器
    • 呼气正压 (PEP) 装置

第七章囊肿纤维化设备市场：依最终用户分类

  • 门诊手术中心
  • 诊所
  • 家庭护理设置
  • 医院
    • 综合医院
    • 专科医院

第八章囊肿纤维化设备市场：依年龄组

  • 成人
    • 老年人
    • 青年
  • 老年医学
  • 小儿科
    • 孩子们
    • 婴儿

第九章囊肿纤维化设备市场治疗

  • 营养疗法
  • 药物治疗
    • 抗生素
    • 黏液溶解剂
  • 物理治疗

第10章美洲囊肿纤维化设备市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第十一章亚太囊性囊肿纤维化器械市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十二章欧洲、中东和非洲囊肿纤维化设备市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十三章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
  • 战略分析和建议
Product Code: MRR-1A1A064C001D

The Cystic Fibrosis Devices Market was valued at USD 2.93 billion in 2023, expected to reach USD 3.20 billion in 2024, and is projected to grow at a CAGR of 10.87%, to USD 6.04 billion by 2030.

Cystic Fibrosis (CF) devices encompass a range of medical technologies designed to assist in the management and treatment of cystic fibrosis, a genetic disorder affecting the respiratory, digestive, and reproductive systems. These devices include nebulizers, airway clearance systems, and oxygen concentrators, essential for improving patients' quality of life by alleviating respiratory symptoms and enhancing pulmonary function. The necessity of these devices is underscored by the chronic nature of CF and the need for lifelong care, facilitating drug delivery, assisting in mucus clearance, and ensuring adequate oxygenation. Application scope spans hospitals, clinics, and home care settings, with end-users including patients, healthcare providers, and caregivers. Market growth is strongly influenced by advances in biotechnology, increasing awareness of cystic fibrosis, and government initiatives to enhance healthcare infrastructure. The rise in personalized medicine and telehealth services introduces potential opportunities, as they can lead to more tailored and accessible treatment options for CF patients. Companies should capitalize on these trends through research and development investments in telemedicine-enabled devices and personalized therapy delivery systems. However, the market faces limitations such as high device costs, limited accessibility in low-income regions, and the complexity of regulatory pathways for new innovations. A significant challenge is also the small patient population, which can limit incentivization for extensive research and development. The best areas for innovation include developing portable and more efficient airway clearance devices, integrating digital health solutions for better patient monitoring, and exploring gene therapy advances for more comprehensive treatment options. The nature of the market is competitive, with significant investments in R&D and collaborations between technology companies and healthcare providers being pivotal for sustained growth. Companies that successfully innovate and navigate regulatory landscapes will be better positioned to capture this growing market.

KEY MARKET STATISTICS
Base Year [2023] USD 2.93 billion
Estimated Year [2024] USD 3.20 billion
Forecast Year [2030] USD 6.04 billion
CAGR (%) 10.87%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Cystic Fibrosis Devices Market

The Cystic Fibrosis Devices Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Growing awareness campaigns and government initiatives for early diagnosis of cystic fibrosis
    • Expansion of clinical trials and approval of new cystic fibrosis management devices
    • Collaborations between healthcare institutions and medical device manufacturers for cystic fibrosis solutions
    • Increasing adoption of personalized medicine approaches in the treatment of cystic fibrosis
  • Market Restraints
    • Stringent regulatory requirements and lengthy approval processes hindering the introduction of new devices
    • Limited funding and resources for research and development slowing innovation in cystic fibrosis care
  • Market Opportunities
    • Creation of digital platforms and mobile apps to enhance cystic fibrosis patient care and support
    • Integration of artificial intelligence in cystic fibrosis device diagnostics and monitoring
    • Establishment of specialized cystic fibrosis clinics with a multidisciplinary care approach
  • Market Challenges
    • Industry-specific challenge: addressing the limited patient population and ensuring market profitability for cystic fibrosis device manufacturers
    • Industry-specific challenge: integrating advanced technologies while maintaining affordability and user-friendliness in cystic fibrosis devices

Porter's Five Forces: A Strategic Tool for Navigating the Cystic Fibrosis Devices Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Cystic Fibrosis Devices Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Cystic Fibrosis Devices Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Cystic Fibrosis Devices Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Cystic Fibrosis Devices Market

A detailed market share analysis in the Cystic Fibrosis Devices Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Cystic Fibrosis Devices Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Cystic Fibrosis Devices Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Cystic Fibrosis Devices Market

A strategic analysis of the Cystic Fibrosis Devices Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Cystic Fibrosis Devices Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, AbbVie Inc., Allergan plc, AstraZeneca plc, Bayer AG, Boehringer Ingelheim International GmbH, Chiesi Farmaceutici S.p.A., Cyclacel Pharmaceuticals, Inc., F. Hoffmann-La Roche Ltd, Gilead Sciences, Inc., GlaxoSmithKline plc, Mylan N.V., Novartis AG, Pfizer Inc., ProQR Therapeutics N.V., Proteostasis Therapeutics, Inc., Sanofi, Teva Pharmaceutical Industries Ltd., Translate Bio, Inc., and Vertex Pharmaceuticals Incorporated.

Market Segmentation & Coverage

This research report categorizes the Cystic Fibrosis Devices Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Product, market is studied across Accessories and Devices. The Accessories is further studied across Masks, Sensors, and Tubes. The Devices is further studied across Airway Clearance Devices, High Frequency Chest Wall Oscillation Devices, Inhalers, Nebulizers, and Positive Expiratory Pressure (PEP) Devices.
  • Based on End User, market is studied across Ambulatory Surgical Centers, Clinics, Homecare Settings, and Hospitals. The Hospitals is further studied across General Hospitals and Specialized Hospitals.
  • Based on Age Group, market is studied across Adults, Geriatrics, and Pediatrics. The Adults is further studied across Older Adults and Young Adults. The Pediatrics is further studied across Children and Infants.
  • Based on Therapy, market is studied across Nutritional Therapy, Pharmacotherapy, and Physiotherapy. The Pharmacotherapy is further studied across Antibiotics and Mucolytics.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Growing awareness campaigns and government initiatives for early diagnosis of cystic fibrosis
      • 5.1.1.2. Expansion of clinical trials and approval of new cystic fibrosis management devices
      • 5.1.1.3. Collaborations between healthcare institutions and medical device manufacturers for cystic fibrosis solutions
      • 5.1.1.4. Increasing adoption of personalized medicine approaches in the treatment of cystic fibrosis
    • 5.1.2. Restraints
      • 5.1.2.1. Stringent regulatory requirements and lengthy approval processes hindering the introduction of new devices
      • 5.1.2.2. Limited funding and resources for research and development slowing innovation in cystic fibrosis care
    • 5.1.3. Opportunities
      • 5.1.3.1. Creation of digital platforms and mobile apps to enhance cystic fibrosis patient care and support
      • 5.1.3.2. Integration of artificial intelligence in cystic fibrosis device diagnostics and monitoring
      • 5.1.3.3. Establishment of specialized cystic fibrosis clinics with a multidisciplinary care approach
    • 5.1.4. Challenges
      • 5.1.4.1. Industry-specific challenge: addressing the limited patient population and ensuring market profitability for cystic fibrosis device manufacturers
      • 5.1.4.2. Industry-specific challenge: integrating advanced technologies while maintaining affordability and user-friendliness in cystic fibrosis devices
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Cystic Fibrosis Devices Market, by Product

  • 6.1. Introduction
  • 6.2. Accessories
    • 6.2.1. Masks
    • 6.2.2. Sensors
    • 6.2.3. Tubes
  • 6.3. Devices
    • 6.3.1. Airway Clearance Devices
    • 6.3.2. High Frequency Chest Wall Oscillation Devices
    • 6.3.3. Inhalers
    • 6.3.4. Nebulizers
    • 6.3.5. Positive Expiratory Pressure (PEP) Devices

7. Cystic Fibrosis Devices Market, by End User

  • 7.1. Introduction
  • 7.2. Ambulatory Surgical Centers
  • 7.3. Clinics
  • 7.4. Homecare Settings
  • 7.5. Hospitals
    • 7.5.1. General Hospitals
    • 7.5.2. Specialized Hospitals

8. Cystic Fibrosis Devices Market, by Age Group

  • 8.1. Introduction
  • 8.2. Adults
    • 8.2.1. Older Adults
    • 8.2.2. Young Adults
  • 8.3. Geriatrics
  • 8.4. Pediatrics
    • 8.4.1. Children
    • 8.4.2. Infants

9. Cystic Fibrosis Devices Market, by Therapy

  • 9.1. Introduction
  • 9.2. Nutritional Therapy
  • 9.3. Pharmacotherapy
    • 9.3.1. Antibiotics
    • 9.3.2. Mucolytics
  • 9.4. Physiotherapy

10. Americas Cystic Fibrosis Devices Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Cystic Fibrosis Devices Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Cystic Fibrosis Devices Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. Market Share Analysis, 2023
  • 13.2. FPNV Positioning Matrix, 2023
  • 13.3. Competitive Scenario Analysis
  • 13.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Abbott Laboratories
  • 2. AbbVie Inc.
  • 3. Allergan plc
  • 4. AstraZeneca plc
  • 5. Bayer AG
  • 6. Boehringer Ingelheim International GmbH
  • 7. Chiesi Farmaceutici S.p.A.
  • 8. Cyclacel Pharmaceuticals, Inc.
  • 9. F. Hoffmann-La Roche Ltd
  • 10. Gilead Sciences, Inc.
  • 11. GlaxoSmithKline plc
  • 12. Mylan N.V.
  • 13. Novartis AG
  • 14. Pfizer Inc.
  • 15. ProQR Therapeutics N.V.
  • 16. Proteostasis Therapeutics, Inc.
  • 17. Sanofi
  • 18. Teva Pharmaceutical Industries Ltd.
  • 19. Translate Bio, Inc.
  • 20. Vertex Pharmaceuticals Incorporated

LIST OF FIGURES

  • FIGURE 1. CYSTIC FIBROSIS DEVICES MARKET RESEARCH PROCESS
  • FIGURE 2. CYSTIC FIBROSIS DEVICES MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL CYSTIC FIBROSIS DEVICES MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL CYSTIC FIBROSIS DEVICES MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL CYSTIC FIBROSIS DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL CYSTIC FIBROSIS DEVICES MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL CYSTIC FIBROSIS DEVICES MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL CYSTIC FIBROSIS DEVICES MARKET SIZE, BY END USER, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL CYSTIC FIBROSIS DEVICES MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL CYSTIC FIBROSIS DEVICES MARKET SIZE, BY AGE GROUP, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL CYSTIC FIBROSIS DEVICES MARKET SIZE, BY AGE GROUP, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL CYSTIC FIBROSIS DEVICES MARKET SIZE, BY THERAPY, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL CYSTIC FIBROSIS DEVICES MARKET SIZE, BY THERAPY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. AMERICAS CYSTIC FIBROSIS DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. AMERICAS CYSTIC FIBROSIS DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. UNITED STATES CYSTIC FIBROSIS DEVICES MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 17. UNITED STATES CYSTIC FIBROSIS DEVICES MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. ASIA-PACIFIC CYSTIC FIBROSIS DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. ASIA-PACIFIC CYSTIC FIBROSIS DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA CYSTIC FIBROSIS DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 21. EUROPE, MIDDLE EAST & AFRICA CYSTIC FIBROSIS DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. CYSTIC FIBROSIS DEVICES MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 23. CYSTIC FIBROSIS DEVICES MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. CYSTIC FIBROSIS DEVICES MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL CYSTIC FIBROSIS DEVICES MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL CYSTIC FIBROSIS DEVICES MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL CYSTIC FIBROSIS DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. CYSTIC FIBROSIS DEVICES MARKET DYNAMICS
  • TABLE 7. GLOBAL CYSTIC FIBROSIS DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL CYSTIC FIBROSIS DEVICES MARKET SIZE, BY ACCESSORIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL CYSTIC FIBROSIS DEVICES MARKET SIZE, BY MASKS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL CYSTIC FIBROSIS DEVICES MARKET SIZE, BY SENSORS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL CYSTIC FIBROSIS DEVICES MARKET SIZE, BY TUBES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL CYSTIC FIBROSIS DEVICES MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL CYSTIC FIBROSIS DEVICES MARKET SIZE, BY DEVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL CYSTIC FIBROSIS DEVICES MARKET SIZE, BY AIRWAY CLEARANCE DEVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL CYSTIC FIBROSIS DEVICES MARKET SIZE, BY HIGH FREQUENCY CHEST WALL OSCILLATION DEVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL CYSTIC FIBROSIS DEVICES MARKET SIZE, BY INHALERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL CYSTIC FIBROSIS DEVICES MARKET SIZE, BY NEBULIZERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL CYSTIC FIBROSIS DEVICES MARKET SIZE, BY POSITIVE EXPIRATORY PRESSURE (PEP) DEVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL CYSTIC FIBROSIS DEVICES MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL CYSTIC FIBROSIS DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL CYSTIC FIBROSIS DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL CYSTIC FIBROSIS DEVICES MARKET SIZE, BY CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL CYSTIC FIBROSIS DEVICES MARKET SIZE, BY HOMECARE SETTINGS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL CYSTIC FIBROSIS DEVICES MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL CYSTIC FIBROSIS DEVICES MARKET SIZE, BY GENERAL HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL CYSTIC FIBROSIS DEVICES MARKET SIZE, BY SPECIALIZED HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL CYSTIC FIBROSIS DEVICES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
  • TABLE 28. GLOBAL CYSTIC FIBROSIS DEVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 29. GLOBAL CYSTIC FIBROSIS DEVICES MARKET SIZE, BY ADULTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 30. GLOBAL CYSTIC FIBROSIS DEVICES MARKET SIZE, BY OLDER ADULTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 31. GLOBAL CYSTIC FIBROSIS DEVICES MARKET SIZE, BY YOUNG ADULTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 32. GLOBAL CYSTIC FIBROSIS DEVICES MARKET SIZE, BY ADULTS, 2018-2030 (USD MILLION)
  • TABLE 33. GLOBAL CYSTIC FIBROSIS DEVICES MARKET SIZE, BY GERIATRICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 34. GLOBAL CYSTIC FIBROSIS DEVICES MARKET SIZE, BY PEDIATRICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 35. GLOBAL CYSTIC FIBROSIS DEVICES MARKET SIZE, BY CHILDREN, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 36. GLOBAL CYSTIC FIBROSIS DEVICES MARKET SIZE, BY INFANTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 37. GLOBAL CYSTIC FIBROSIS DEVICES MARKET SIZE, BY PEDIATRICS, 2018-2030 (USD MILLION)
  • TABLE 38. GLOBAL CYSTIC FIBROSIS DEVICES MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 39. GLOBAL CYSTIC FIBROSIS DEVICES MARKET SIZE, BY NUTRITIONAL THERAPY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 40. GLOBAL CYSTIC FIBROSIS DEVICES MARKET SIZE, BY PHARMACOTHERAPY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 41. GLOBAL CYSTIC FIBROSIS DEVICES MARKET SIZE, BY ANTIBIOTICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 42. GLOBAL CYSTIC FIBROSIS DEVICES MARKET SIZE, BY MUCOLYTICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 43. GLOBAL CYSTIC FIBROSIS DEVICES MARKET SIZE, BY PHARMACOTHERAPY, 2018-2030 (USD MILLION)
  • TABLE 44. GLOBAL CYSTIC FIBROSIS DEVICES MARKET SIZE, BY PHYSIOTHERAPY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 45. AMERICAS CYSTIC FIBROSIS DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 46. AMERICAS CYSTIC FIBROSIS DEVICES MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
  • TABLE 47. AMERICAS CYSTIC FIBROSIS DEVICES MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 48. AMERICAS CYSTIC FIBROSIS DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 49. AMERICAS CYSTIC FIBROSIS DEVICES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
  • TABLE 50. AMERICAS CYSTIC FIBROSIS DEVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 51. AMERICAS CYSTIC FIBROSIS DEVICES MARKET SIZE, BY ADULTS, 2018-2030 (USD MILLION)
  • TABLE 52. AMERICAS CYSTIC FIBROSIS DEVICES MARKET SIZE, BY PEDIATRICS, 2018-2030 (USD MILLION)
  • TABLE 53. AMERICAS CYSTIC FIBROSIS DEVICES MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 54. AMERICAS CYSTIC FIBROSIS DEVICES MARKET SIZE, BY PHARMACOTHERAPY, 2018-2030 (USD MILLION)
  • TABLE 55. AMERICAS CYSTIC FIBROSIS DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 56. ARGENTINA CYSTIC FIBROSIS DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 57. ARGENTINA CYSTIC FIBROSIS DEVICES MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
  • TABLE 58. ARGENTINA CYSTIC FIBROSIS DEVICES MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 59. ARGENTINA CYSTIC FIBROSIS DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 60. ARGENTINA CYSTIC FIBROSIS DEVICES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
  • TABLE 61. ARGENTINA CYSTIC FIBROSIS DEVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 62. ARGENTINA CYSTIC FIBROSIS DEVICES MARKET SIZE, BY ADULTS, 2018-2030 (USD MILLION)
  • TABLE 63. ARGENTINA CYSTIC FIBROSIS DEVICES MARKET SIZE, BY PEDIATRICS, 2018-2030 (USD MILLION)
  • TABLE 64. ARGENTINA CYSTIC FIBROSIS DEVICES MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 65. ARGENTINA CYSTIC FIBROSIS DEVICES MARKET SIZE, BY PHARMACOTHERAPY, 2018-2030 (USD MILLION)
  • TABLE 66. BRAZIL CYSTIC FIBROSIS DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 67. BRAZIL CYSTIC FIBROSIS DEVICES MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
  • TABLE 68. BRAZIL CYSTIC FIBROSIS DEVICES MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 69. BRAZIL CYSTIC FIBROSIS DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 70. BRAZIL CYSTIC FIBROSIS DEVICES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
  • TABLE 71. BRAZIL CYSTIC FIBROSIS DEVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 72. BRAZIL CYSTIC FIBROSIS DEVICES MARKET SIZE, BY ADULTS, 2018-2030 (USD MILLION)
  • TABLE 73. BRAZIL CYSTIC FIBROSIS DEVICES MARKET SIZE, BY PEDIATRICS, 2018-2030 (USD MILLION)
  • TABLE 74. BRAZIL CYSTIC FIBROSIS DEVICES MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 75. BRAZIL CYSTIC FIBROSIS DEVICES MARKET SIZE, BY PHARMACOTHERAPY, 2018-2030 (USD MILLION)
  • TABLE 76. CANADA CYSTIC FIBROSIS DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 77. CANADA CYSTIC FIBROSIS DEVICES MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
  • TABLE 78. CANADA CYSTIC FIBROSIS DEVICES MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 79. CANADA CYSTIC FIBROSIS DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 80. CANADA CYSTIC FIBROSIS DEVICES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
  • TABLE 81. CANADA CYSTIC FIBROSIS DEVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 82. CANADA CYSTIC FIBROSIS DEVICES MARKET SIZE, BY ADULTS, 2018-2030 (USD MILLION)
  • TABLE 83. CANADA CYSTIC FIBROSIS DEVICES MARKET SIZE, BY PEDIATRICS, 2018-2030 (USD MILLION)
  • TABLE 84. CANADA CYSTIC FIBROSIS DEVICES MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 85. CANADA CYSTIC FIBROSIS DEVICES MARKET SIZE, BY PHARMACOTHERAPY, 2018-2030 (USD MILLION)
  • TABLE 86. MEXICO CYSTIC FIBROSIS DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 87. MEXICO CYSTIC FIBROSIS DEVICES MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
  • TABLE 88. MEXICO CYSTIC FIBROSIS DEVICES MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 89. MEXICO CYSTIC FIBROSIS DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 90. MEXICO CYSTIC FIBROSIS DEVICES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
  • TABLE 91. MEXICO CYSTIC FIBROSIS DEVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 92. MEXICO CYSTIC FIBROSIS DEVICES MARKET SIZE, BY ADULTS, 2018-2030 (USD MILLION)
  • TABLE 93. MEXICO CYSTIC FIBROSIS DEVICES MARKET SIZE, BY PEDIATRICS, 2018-2030 (USD MILLION)
  • TABLE 94. MEXICO CYSTIC FIBROSIS DEVICES MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 95. MEXICO CYSTIC FIBROSIS DEVICES MARKET SIZE, BY PHARMACOTHERAPY, 2018-2030 (USD MILLION)
  • TABLE 96. UNITED STATES CYSTIC FIBROSIS DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 97. UNITED STATES CYSTIC FIBROSIS DEVICES MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
  • TABLE 98. UNITED STATES CYSTIC FIBROSIS DEVICES MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 99. UNITED STATES CYSTIC FIBROSIS DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 100. UNITED STATES CYSTIC FIBROSIS DEVICES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
  • TABLE 101. UNITED STATES CYSTIC FIBROSIS DEVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 102. UNITED STATES CYSTIC FIBROSIS DEVICES MARKET SIZE, BY ADULTS, 2018-2030 (USD MILLION)
  • TABLE 103. UNITED STATES CYSTIC FIBROSIS DEVICES MARKET SIZE, BY PEDIATRICS, 2018-2030 (USD MILLION)
  • TABLE 104. UNITED STATES CYSTIC FIBROSIS DEVICES MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 105. UNITED STATES CYSTIC FIBROSIS DEVICES MARKET SIZE, BY PHARMACOTHERAPY, 2018-2030 (USD MILLION)
  • TABLE 106. UNITED STATES CYSTIC FIBROSIS DEVICES MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 107. ASIA-PACIFIC CYSTIC FIBROSIS DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 108. ASIA-PACIFIC CYSTIC FIBROSIS DEVICES MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
  • TABLE 109. ASIA-PACIFIC CYSTIC FIBROSIS DEVICES MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 110. ASIA-PACIFIC CYSTIC FIBROSIS DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 111. ASIA-PACIFIC CYSTIC FIBROSIS DEVICES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
  • TABLE 112. ASIA-PACIFIC CYSTIC FIBROSIS DEVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 113. ASIA-PACIFIC CYSTIC FIBROSIS DEVICES MARKET SIZE, BY ADULTS, 2018-2030 (USD MILLION)
  • TABLE 114. ASIA-PACIFIC CYSTIC FIBROSIS DEVICES MARKET SIZE, BY PEDIATRICS, 2018-2030 (USD MILLION)
  • TABLE 115. ASIA-PACIFIC CYSTIC FIBROSIS DEVICES MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 116. ASIA-PACIFIC CYSTIC FIBROSIS DEVICES MARKET SIZE, BY PHARMACOTHERAPY, 2018-2030 (USD MILLION)
  • TABLE 117. ASIA-PACIFIC CYSTIC FIBROSIS DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 118. AUSTRALIA CYSTIC FIBROSIS DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 119. AUSTRALIA CYSTIC FIBROSIS DEVICES MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
  • TABLE 120. AUSTRALIA CYSTIC FIBROSIS DEVICES MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 121. AUSTRALIA CYSTIC FIBROSIS DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 122. AUSTRALIA CYSTIC FIBROSIS DEVICES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
  • TABLE 123. AUSTRALIA CYSTIC FIBROSIS DEVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 124. AUSTRALIA CYSTIC FIBROSIS DEVICES MARKET SIZE, BY ADULTS, 2018-2030 (USD MILLION)
  • TABLE 125. AUSTRALIA CYSTIC FIBROSIS DEVICES MARKET SIZE, BY PEDIATRICS, 2018-2030 (USD MILLION)
  • TABLE 126. AUSTRALIA CYSTIC FIBROSIS DEVICES MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 127. AUSTRALIA CYSTIC FIBROSIS DEVICES MARKET SIZE, BY PHARMACOTHERAPY, 2018-2030 (USD MILLION)
  • TABLE 128. CHINA CYSTIC FIBROSIS DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 129. CHINA CYSTIC FIBROSIS DEVICES MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
  • TABLE 130. CHINA CYSTIC FIBROSIS DEVICES MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 131. CHINA CYSTIC FIBROSIS DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 132. CHINA CYSTIC FIBROSIS DEVICES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
  • TABLE 133. CHINA CYSTIC FIBROSIS DEVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 134. CHINA CYSTIC FIBROSIS DEVICES MARKET SIZE, BY ADULTS, 2018-2030 (USD MILLION)
  • TABLE 135. CHINA CYSTIC FIBROSIS DEVICES MARKET SIZE, BY PEDIATRICS, 2018-2030 (USD MILLION)
  • TABLE 136. CHINA CYSTIC FIBROSIS DEVICES MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 137. CHINA CYSTIC FIBROSIS DEVICES MARKET SIZE, BY PHARMACOTHERAPY, 2018-2030 (USD MILLION)
  • TABLE 138. INDIA CYSTIC FIBROSIS DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 139. INDIA CYSTIC FIBROSIS DEVICES MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
  • TABLE 140. INDIA CYSTIC FIBROSIS DEVICES MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 141. INDIA CYSTIC FIBROSIS DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 142. INDIA CYSTIC FIBROSIS DEVICES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
  • TABLE 143. INDIA CYSTIC FIBROSIS DEVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 144. INDIA CYSTIC FIBROSIS DEVICES MARKET SIZE, BY ADULTS, 2018-2030 (USD MILLION)
  • TABLE 145. INDIA CYSTIC FIBROSIS DEVICES MARKET SIZE, BY PEDIATRICS, 2018-2030 (USD MILLION)
  • TABLE 146. INDIA CYSTIC FIBROSIS DEVICES MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 147. INDIA CYSTIC FIBROSIS DEVICES MARKET SIZE, BY PHARMACOTHERAPY, 2018-2030 (USD MILLION)
  • TABLE 148. INDONESIA CYSTIC FIBROSIS DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 149. INDONESIA CYSTIC FIBROSIS DEVICES MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
  • TABLE 150. INDONESIA CYSTIC FIBROSIS DEVICES MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 151. INDONESIA CYSTIC FIBROSIS DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 152. INDONESIA CYSTIC FIBROSIS DEVICES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
  • TABLE 153. INDONESIA CYSTIC FIBROSIS DEVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 154. INDONESIA CYSTIC FIBROSIS DEVICES MARKET SIZE, BY ADULTS, 2018-2030 (USD MILLION)
  • TABLE 155. INDONESIA CYSTIC FIBROSIS DEVICES MARKET SIZE, BY PEDIATRICS, 2018-2030 (USD MILLION)
  • TABLE 156. INDONESIA CYSTIC FIBROSIS DEVICES MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 157. INDONESIA CYSTIC FIBROSIS DEVICES MARKET SIZE, BY PHARMACOTHERAPY, 2018-2030 (USD MILLION)
  • TABLE 158. JAPAN CYSTIC FIBROSIS DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 159. JAPAN CYSTIC FIBROSIS DEVICES MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
  • TABLE 160. JAPAN CYSTIC FIBROSIS DEVICES MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 161. JAPAN CYSTIC FIBROSIS DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 162. JAPAN CYSTIC FIBROSIS DEVICES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
  • TABLE 163. JAPAN CYSTIC FIBROSIS DEVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 164. JAPAN CYSTIC FIBROSIS DEVICES MARKET SIZE, BY ADULTS, 2018-2030 (USD MILLION)
  • TABLE 165. JAPAN CYSTIC FIBROSIS DEVICES MARKET SIZE, BY PEDIATRICS, 2018-2030 (USD MILLION)
  • TABLE 166. JAPAN CYSTIC FIBROSIS DEVICES MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 167. JAPAN CYSTIC FIBROSIS DEVICES MARKET SIZE, BY PHARMACOTHERAPY, 2018-2030 (USD MILLION)
  • TABLE 168. MALAYSIA CYSTIC FIBROSIS DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 169. MALAYSIA CYSTIC FIBROSIS DEVICES MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
  • TABLE 170. MALAYSIA CYSTIC FIBROSIS DEVICES MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 171. MALAYSIA CYSTIC FIBROSIS DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 172. MALAYSIA CYSTIC FIBROSIS DEVICES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
  • TABLE 173. MALAYSIA CYSTIC FIBROSIS DEVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 174. MALAYSIA CYSTIC FIBROSIS DEVICES MARKET SIZE, BY ADULTS, 2018-2030 (USD MILLION)
  • TABLE 175. MALAYSIA CYSTIC FIBROSIS DEVICES MARKET SIZE, BY PEDIATRICS, 2018-2030 (USD MILLION)
  • TABLE 176. MALAYSIA CYSTIC FIBROSIS DEVICES MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 177. MALAYSIA CYSTIC FIBROSIS DEVICES MARKET SIZE, BY PHARMACOTHERAPY, 2018-2030 (USD MILLION)
  • TABLE 178. PHILIPPINES CYSTIC FIBROSIS DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 179. PHILIPPINES CYSTIC FIBROSIS DEVICES MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
  • TABLE 180. PHILIPPINES CYSTIC FIBROSIS DEVICES MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 181. PHILIPPINES CYSTIC FIBROSIS DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 182. PHILIPPINES CYSTIC FIBROSIS DEVICES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
  • TABLE 183. PHILIPPINES CYSTIC FIBROSIS DEVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 184. PHILIPPINES CYSTIC FIBROSIS DEVICES MARKET SIZE, BY ADULTS, 2018-2030 (USD MILLION)
  • TABLE 185. PHILIPPINES CYSTIC FIBROSIS DEVICES MARKET SIZE, BY PEDIATRICS, 2018-2030 (USD MILLION)
  • TABLE 186. PHILIPPINES CYSTIC FIBROSIS DEVICES MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 187. PHILIPPINES CYSTIC FIBROSIS DEVICES MARKET SIZE, BY PHARMACOTHERAPY, 2018-2030 (USD MILLION)
  • TABLE 188. SINGAPORE CYSTIC FIBROSIS DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 189. SINGAPORE CYSTIC FIBROSIS DEVICES MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
  • TABLE 190. SINGAPORE CYSTIC FIBROSIS DEVICES MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 191. SINGAPORE CYSTIC FIBROSIS DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 192. SINGAPORE CYSTIC FIBROSIS DEVICES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
  • TABLE 193. SINGAPORE CYSTIC FIBROSIS DEVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 194. SINGAPORE CYSTIC FIBROSIS DEVICES MARKET SIZE, BY ADULTS, 2018-2030 (USD MILLION)
  • TABLE 195. SINGAPORE CYSTIC FIBROSIS DEVICES MARKET SIZE, BY PEDIATRICS, 2018-2030 (USD MILLION)
  • TABLE 196. SINGAPORE CYSTIC FIBROSIS DEVICES MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 197. SINGAPORE CYSTIC FIBROSIS DEVICES MARKET SIZE, BY PHARMACOTHERAPY, 2018-2030 (USD MILLION)
  • TABLE 198. SOUTH KOREA CYSTIC FIBROSIS DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 199. SOUTH KOREA CYSTIC FIBROSIS DEVICES MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
  • TABLE 200. SOUTH KOREA CYSTIC FIBROSIS DEVICES MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 201. SOUTH KOREA CYSTIC FIBROSIS DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 202. SOUTH KOREA CYSTIC FIBROSIS DEVICES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
  • TABLE 203. SOUTH KOREA CYSTIC FIBROSIS DEVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 204. SOUTH KOREA CYSTIC FIBROSIS DEVICES MARKET SIZE, BY ADULTS, 2018-2030 (USD MILLION)
  • TABLE 205. SOUTH KOREA CYSTIC FIBROSIS DEVICES MARKET SIZE, BY PEDIATRICS, 2018-2030 (USD MILLION)
  • TABLE 206. SOUTH KOREA CYSTIC FIBROSIS DEVICES MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 207. SOUTH KOREA CYSTIC FIBROSIS DEVICES MARKET SIZE, BY PHARMACOTHERAPY, 2018-2030 (USD MILLION)
  • TABLE 208. TAIWAN CYSTIC FIBROSIS DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 209. TAIWAN CYSTIC FIBROSIS DEVICES MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
  • TABLE 210. TAIWAN CYSTIC FIBROSIS DEVICES MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 211. TAIWAN CYSTIC FIBROSIS DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 212. TAIWAN CYSTIC FIBROSIS DEVICES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
  • TABLE 213. TAIWAN CYSTIC FIBROSIS DEVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 214. TAIWAN CYSTIC FIBROSIS DEVICES MARKET SIZE, BY ADULTS, 2018-2030 (USD MILLION)
  • TABLE 215. TAIWAN CYSTIC FIBROSIS DEVICES MARKET SIZE, BY PEDIATRICS, 2018-2030 (USD MILLION)
  • TABLE 216. TAIWAN CYSTIC FIBROSIS DEVICES MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 217. TAIWAN CYSTIC FIBROSIS DEVICES MARKET SIZE, BY PHARMACOTHERAPY, 2018-2030 (USD MILLION)
  • TABLE 218. THAILAND CYSTIC FIBROSIS DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 219. THAILAND CYSTIC FIBROSIS DEVICES MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
  • TABLE 220. THAILAND CYSTIC FIBROSIS DEVICES MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 221. THAILAND CYSTIC FIBROSIS DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 222. THAILAND CYSTIC FIBROSIS DEVICES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
  • TABLE 223. THAILAND CYSTIC FIBROSIS DEVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 224. THAILAND CYSTIC FIBROSIS DEVICES MARKET SIZE, BY ADULTS, 2018-2030 (USD MILLION)
  • TABLE 225. THAILAND CYSTIC FIBROSIS DEVICES MARKET SIZE, BY PEDIATRICS, 2018-2030 (USD MILLION)
  • TABLE 226. THAILAND CYSTIC FIBROSIS DEVICES MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 227. THAILAND CYSTIC FIBROSIS DEVICES MARKET SIZE, BY PHARMACOTHERAPY, 2018-2030 (USD MILLION)
  • TABLE 228. VIETNAM CYSTIC FIBROSIS DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 229. VIETNAM CYSTIC FIBROSIS DEVICES MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
  • TABLE 230. VIETNAM CYSTIC FIBROSIS DEVICES MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 231. VIETNAM CYSTIC FIBROSIS DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 232. VIETNAM CYSTIC FIBROSIS DEVICES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
  • TABLE 233. VIETNAM CYSTIC FIBROSIS DEVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 234. VIETNAM CYSTIC FIBROSIS DEVICES MARKET SIZE, BY ADULTS, 2018-2030 (USD MILLION)
  • TABLE 235. VIETNAM CYSTIC FIBROSIS DEVICES MARKET SIZE, BY PEDIATRICS, 2018-2030 (USD MILLION)
  • TABLE 236. VIETNAM CYSTIC FIBROSIS DEVICES MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 237. VIETNAM CYSTIC FIBROSIS DEVICES MARKET SIZE, BY PHARMACOTHERAPY, 2018-2030 (USD MILLION)
  • TABLE 238. EUROPE, MIDDLE EAST & AFRICA CYSTIC FIBROSIS DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 239. EUROPE, MIDDLE EAST & AFRICA CYSTIC FIBROSIS DEVICES MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
  • TABLE 240. EUROPE, MIDDLE EAST & AFRICA CYSTIC FIBROSIS DEVICES MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 241. EUROPE, MIDDLE EAST & AFRICA CYSTIC FIBROSIS DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 242. EUROPE, MIDDLE EAST & AFRICA CYSTIC FIBROSIS DEVICES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
  • TABLE 243. EUROPE, MIDDLE EAST & AFRICA CYSTIC FIBROSIS DEVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 244. EUROPE, MIDDLE EAST & AFRICA CYSTIC FIBROSIS DEVICES MARKET SIZE, BY ADULTS, 2018-2030 (USD MILLION)
  • TABLE 245. EUROPE, MIDDLE EAST & AFRICA CYSTIC FIBROSIS DEVICES MARKET SIZE, BY PEDIATRICS, 2018-2030 (USD MILLION)
  • TABLE 246. EUROPE, MIDDLE EAST & AFRICA CYSTIC FIBROSIS DEVICES MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 247. EUROPE, MIDDLE EAST & AFRICA CYSTIC FIBROSIS DEVICES MARKET SIZE, BY PHARMACOTHERAPY, 2018-2030 (USD MILLION)
  • TABLE 248. EUROPE, MIDDLE EAST & AFRICA CYSTIC FIBROSIS DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 249. DENMARK CYSTIC FIBROSIS DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 250. DENMARK CYSTIC FIBROSIS DEVICES MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
  • TABLE 251. DENMARK CYSTIC FIBROSIS DEVICES MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 252. DENMARK CYSTIC FIBROSIS DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 253. DENMARK CYSTIC FIBROSIS DEVICES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
  • TABLE 254. DENMARK CYSTIC FIBROSIS DEVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 255. DENMARK CYSTIC FIBROSIS DEVICES MARKET SIZE, BY ADULTS, 2018-2030 (USD MILLION)
  • TABLE 256. DENMARK CYSTIC FIBROSIS DEVICES MARKET SIZE, BY PEDIATRICS, 2018-2030 (USD MILLION)
  • TABLE 257. DENMARK CYSTIC FIBROSIS DEVICES MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 258. DENMARK CYSTIC FIBROSIS DEVICES MARKET SIZE, BY PHARMACOTHERAPY, 2018-2030 (USD MILLION)
  • TABLE 259. EGYPT CYSTIC FIBROSIS DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 260. EGYPT CYSTIC FIBROSIS DEVICES MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
  • TABLE 261. EGYPT CYSTIC FIBROSIS DEVICES MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 262. EGYPT CYSTIC FIBROSIS DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 263. EGYPT CYSTIC FIBROSIS DEVICES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
  • TABLE 264. EGYPT CYSTIC FIBROSIS DEVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 265. EGYPT CYSTIC FIBROSIS DEVICES MARKET SIZE, BY ADULTS, 2018-2030 (USD MILLION)
  • TABLE 266. EGYPT CYSTIC FIBROSIS DEVICES MARKET SIZE, BY PEDIATRICS, 2018-2030 (USD MILLION)
  • TABLE 267. EGYPT CYSTIC FIBROSIS DEVICES MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 268. EGYPT CYSTIC FIBROSIS DEVICES MARKET SIZE, BY PHARMACOTHERAPY, 2018-2030 (USD MILLION)
  • TABLE 269. FINLAND CYSTIC FIBROSIS DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 270. FINLAND CYSTIC FIBROSIS DEVICES MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
  • TABLE 271. FINLAND CYSTIC FIBROSIS DEVICES MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 272. FINLAND CYSTIC FIBROSIS DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 273. FINLAND CYSTIC FIBROSIS DEVICES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
  • TABLE 274. FINLAND CYSTIC FIBROSIS DEVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 275. FINLAND CYSTIC FIBROSIS DEVICES MARKET SIZE, BY ADULTS, 2018-2030 (USD MILLION)
  • TABLE 276. FINLAND CYSTIC FIBROSIS DEVICES MARKET SIZE, BY PEDIATRICS, 2018-2030 (USD MILLION)
  • TABLE 277. FINLAND CYSTIC FIBROSIS DEVICES MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 278. FINLAND CYSTIC FIBROSIS DEVICES MARKET SIZE, BY PHARMACOTHERAPY, 2018-2030 (USD MILLION)
  • TABLE 279. FRANCE CYSTIC FIBROSIS DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 280. FRANCE CYSTIC FIBROSIS DEVICES MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
  • TABLE 281. FRANCE CYSTIC FIBROSIS DEVICES MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 282. FRANCE CYSTIC FIBROSIS DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 283. FRANCE CYSTIC FIBROSIS DEVICES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
  • TABLE 284. FRANCE CYSTIC FIBROSIS DEVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 285. FRANCE CYSTIC FIBROSIS DEVICES MARKET SIZE, BY ADULTS, 2018-2030 (USD MILLION)
  • TABLE 286. FRANCE CYSTIC FIBROSIS DEVICES MARKET SIZE, BY PEDIATRICS, 2018-2030 (USD MILLION)
  • TABLE 287. FRANCE CYSTIC FIBROSIS DEVICES MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 288. FRANCE CYSTIC FIBROSIS DEVICES MARKET SIZE, BY PHARMACOTHERAPY, 2018-2030 (USD MILLION)
  • TABLE 289. GERMANY CYSTIC FIBROSIS DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 290. GERMANY CYSTIC FIBROSIS DEVICES MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
  • TABLE 291. GERMANY CYSTIC FIBROSIS DEVICES MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 292. GERMANY CYSTIC FIBROSIS DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 293. GERMANY CYSTIC FIBROSIS DEVICES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
  • TABLE 294. GERMANY CYSTIC FIBROSIS DEVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 295. GERMANY CYSTIC FIBROSIS DEVICES MARKET SIZE, BY ADULTS, 2018-2030 (USD MILLION)
  • TABLE 296. GERMANY CYSTIC FIBROSIS DEVICES MARKET SIZE, BY PEDIATRICS, 2018-2030 (USD MILLION)
  • TABLE 297. GERMANY CYSTIC FIBROSIS DEVICES MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 298. GERMANY CYSTIC FIBROSIS DEVICES MARKET SIZE, BY PHARMACOTHERAPY, 2018-2030 (USD MILLION)
  • TABLE 299. ISRAEL CYSTIC FIBROSIS DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 300. ISRAEL CYSTIC FIBROSIS DEVICES MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
  • TABLE 301. ISRAEL CYSTIC FIBROSIS DEVICES MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 302. ISRAEL CYSTIC FIBROSIS DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 303. ISRAEL CYSTIC FIBROSIS DEVICES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
  • TABLE 304. ISRAEL CYSTIC FIBROSIS DEVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 305. ISRAEL CYSTIC FIBROSIS DEVICES MARKET SIZE, BY ADULTS, 2018-2030 (USD MILLION)
  • TABLE 306. ISRAEL CYSTIC FIBROSIS DEVICES MARKET SIZE, BY PEDIATRICS, 2018-2030 (USD MILLION)
  • TABLE 307. ISRAEL CYSTIC FIBROSIS DEVICES MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 308. ISRAEL CYSTIC FIBROSIS DEVICES MARKET SIZE, BY PHARMACOTHERAPY, 2018-2030 (USD MILLION)
  • TABLE 309. ITALY CYSTIC FIBROSIS DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 310. ITALY CYSTIC FIBROSIS DEVICES MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
  • TABLE 311. ITALY CYSTIC FIBROSIS DEVICES MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 312. ITALY CYSTIC FIBROSIS DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 313. ITALY CYSTIC FIBROSIS DEVICES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
  • TABLE 314. ITALY CYSTIC FIBROSIS DEVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 315. ITALY CYSTIC FIBROSIS DEVICES MARKET SIZE, BY ADULTS, 2018-2030 (USD MILLION)
  • TABLE 316. ITALY CYSTIC FIBROSIS DEVICES MARKET SIZE, BY PEDIATRICS, 2018-2030 (USD MILLION)
  • TABLE 317. ITALY CYSTIC FIBROSIS DEVICES MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 318. ITALY CYSTIC FIBROSIS DEVICES MARKET SIZE, BY PHARMACOTHERAPY, 2018-2030 (USD MILLION)
  • TABLE 319. NETHERLANDS CYSTIC FIBROSIS DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 320. NETHERLANDS CYSTIC FIBROSIS DEVICES MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
  • TABLE 321. NETHERLANDS CYSTIC FIBROSIS DEVICES MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 322. NETHERLANDS CYSTIC FIBROSIS DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 323. NETHERLANDS CYSTIC FIBROSIS DEVICES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
  • TABLE 324. NETHERLANDS CYSTIC FIBROSIS DEVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 325. NETHERLANDS CYSTIC FIBROSIS DEVICES MARKET SIZE, BY ADULTS, 2018-2030 (USD MILLION)
  • TABLE 326. NETHERLANDS CYSTIC FIBROSIS DEVICES MARKET SIZE, BY PEDIATRICS, 2018-2030 (USD MILLION)
  • TABLE 327. NETHERLANDS CYSTIC FIBROSIS DEVICES MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 328. NETHERLANDS CYSTIC FIBROSIS DEVICES MARKET SIZE, BY PHARMACOTHERAPY, 2018-2030 (USD MILLION)
  • TABLE 329. NIGERIA CYSTIC FIBROSIS DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 330. NIGERIA CYSTIC FIBROSIS DEVICES MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
  • TABLE 331. NIGERIA CYSTIC FIBROSIS DEVICES MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 332. NIGERIA CYSTIC FIBROSIS DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 333. NIGERIA CYSTIC FIBROSIS DEVICES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
  • TABLE 334. NIGERIA CYSTIC FIBROSIS DEVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 335. NIGERIA CYSTIC FIBROSIS DEVICES MARKET SIZE, BY ADULTS, 2018-2030 (USD MILLION)
  • TABLE 336. NIGERIA CYSTIC FIBROSIS DEVICES MARKET SIZE, BY PEDIATRICS, 2018-2030 (USD MILLION)
  • TABLE 337. NIGERIA CYSTIC FIBROSIS DEVICES MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 338. NIGERIA CYSTIC FIBROSIS DEVICES MARKET SIZE, BY PHARMACOTHERAPY, 2018-2030 (USD MILLION)
  • TABLE 339. NORWAY CYSTIC FIBROSIS DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 340. NORWAY CYSTIC FIBROSIS DEVICES MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
  • TABLE 341. NORWAY CYSTIC FIBROSIS DEVICES MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 342. NORWAY CYSTIC FIBROSIS DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 343. NORWAY CYSTIC FIBROSIS DEVICES MARKET SIZE, BY HOSPITAL